Marcia Stefanick

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. pmc Family history of later-onset breast cancer, breast healthy behavior and invasive breast cancer among postmenopausal women: a cohort study
    Robert Gramling
    Department of Family Medicine, University of Rochester, NY 14620, USA
    Breast Cancer Res 12:R82. 2010
  2. ncbi request reprint Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration
    Marcia L Stefanick
    Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, California 94305 5705, USA
    Am J Med 118:64-73. 2005
  3. doi request reprint Postmenopausal hormone therapy and cardiovascular disease in women
    M L Stefanick
    Stanford Prevention Research Center, Stanford University School of Medicine, Medical School Office Building, 251 Campus Drive, Room X308, Stanford, CA 94305 5411, United States
    Nutr Metab Cardiovasc Dis 20:451-8. 2010
  4. ncbi request reprint Reanalysis of the Women's Health Initiative oral contraceptive data reveals no evidence of delayed cardiovascular benefit
    Marcia L Stefanick
    Stanford Prevention Research Center, Departments of Medicine and of Obstetrics and Gynecology, Hoover Pavilion, Stanford University, 211 Quarry Road, Stanford, CA 94305 5705, USA
    Fertil Steril 83:853-4. 2005
  5. ncbi request reprint Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy
    Marcia L Stefanick
    Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, Calif 94305, USA
    JAMA 295:1647-57. 2006
  6. doi request reprint Gendered innovations: a new approach for nursing science
    Stacy T Sims
    Stanford Prevention Research Center, Stanford School of Medicine, Stanford, CA, USA
    Biol Res Nurs 12:156-61. 2010
  7. ncbi request reprint National use of postmenopausal hormone therapy: annual trends and response to recent evidence
    Adam L Hersh
    Stanford Prevention Research Center, Program on Prevention Outcomes and Practices, Stanford University School of Medicine, Stanford, Calif 94305, USA
    JAMA 291:47-53. 2004
  8. ncbi request reprint Mortality and cardiac and vascular outcomes in extremely obese women
    Kathleen McTigue
    Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA
    JAMA 296:79-86. 2006
  9. ncbi request reprint The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants
    Marcia L Stefanick
    Stanford Center for Research in Disease Prevention, Stanford University, Palo Alto, CA, USA
    Ann Epidemiol 13:S78-86. 2003
  10. ncbi request reprint Compliance with National Cholesterol Education Program dietary and lifestyle guidelines among older women with self-reported hypercholesterolemia. The Women's Health Initiative
    Judith Hsia
    Department of Medicine, George Washington University, Washington, DC, USA
    Am J Med 113:384-92. 2002

Research Grants

  1. Outcomes of Sleep Disorders in Older Men-Palo Alto
    Marcia Stefanick; Fiscal Year: 2007
  2. OSTEOPOROTIC FRACTURES IN MEN
    Marcia Stefanick; Fiscal Year: 2007

Collaborators

Detail Information

Publications64

  1. pmc Family history of later-onset breast cancer, breast healthy behavior and invasive breast cancer among postmenopausal women: a cohort study
    Robert Gramling
    Department of Family Medicine, University of Rochester, NY 14620, USA
    Breast Cancer Res 12:R82. 2010
    ....
  2. ncbi request reprint Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration
    Marcia L Stefanick
    Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, California 94305 5705, USA
    Am J Med 118:64-73. 2005
    ....
  3. doi request reprint Postmenopausal hormone therapy and cardiovascular disease in women
    M L Stefanick
    Stanford Prevention Research Center, Stanford University School of Medicine, Medical School Office Building, 251 Campus Drive, Room X308, Stanford, CA 94305 5411, United States
    Nutr Metab Cardiovasc Dis 20:451-8. 2010
    ..This article reviews the literature regarding HT and CHD, with emphasis on the findings from the WHI trials...
  4. ncbi request reprint Reanalysis of the Women's Health Initiative oral contraceptive data reveals no evidence of delayed cardiovascular benefit
    Marcia L Stefanick
    Stanford Prevention Research Center, Departments of Medicine and of Obstetrics and Gynecology, Hoover Pavilion, Stanford University, 211 Quarry Road, Stanford, CA 94305 5705, USA
    Fertil Steril 83:853-4. 2005
    ..The WHI database was not designed to answer this question...
  5. ncbi request reprint Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy
    Marcia L Stefanick
    Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, Calif 94305, USA
    JAMA 295:1647-57. 2006
    ..Preliminary results suggesting possible reduction in breast cancers warranted more detailed analysis...
  6. doi request reprint Gendered innovations: a new approach for nursing science
    Stacy T Sims
    Stanford Prevention Research Center, Stanford School of Medicine, Stanford, CA, USA
    Biol Res Nurs 12:156-61. 2010
    ..The authors also provide recommendations for incorporating the concepts of sex and gender analysis into nursing education and research...
  7. ncbi request reprint National use of postmenopausal hormone therapy: annual trends and response to recent evidence
    Adam L Hersh
    Stanford Prevention Research Center, Program on Prevention Outcomes and Practices, Stanford University School of Medicine, Stanford, Calif 94305, USA
    JAMA 291:47-53. 2004
    ..Recent evidence from randomized trials published in July 2002 demonstrated adverse cardiovascular disease events and other risks with hormone therapy in the form of oral estrogen combined with progestin...
  8. ncbi request reprint Mortality and cardiac and vascular outcomes in extremely obese women
    Kathleen McTigue
    Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA
    JAMA 296:79-86. 2006
    ..9); obesity 2 (35-39.9); and extreme obesity (> or =40). Extreme obesity is increasing particularly rapidly in the United States, yet its health risks are not well characterized...
  9. ncbi request reprint The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants
    Marcia L Stefanick
    Stanford Center for Research in Disease Prevention, Stanford University, Palo Alto, CA, USA
    Ann Epidemiol 13:S78-86. 2003
  10. ncbi request reprint Compliance with National Cholesterol Education Program dietary and lifestyle guidelines among older women with self-reported hypercholesterolemia. The Women's Health Initiative
    Judith Hsia
    Department of Medicine, George Washington University, Washington, DC, USA
    Am J Med 113:384-92. 2002
    ..Dietary therapy remains the first line of treatment for patients with high blood cholesterol levels. Among free-living persons, compliance with National Cholesterol Education Program (NCEP) dietary recommendations is uncertain...
  11. pmc Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study
    Ross L Prentice
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Epidemiol 167:1407-15. 2008
    ....
  12. pmc Hip bone density predicts breast cancer risk independently of Gail score: results from the Women's Health Initiative
    Zhao Chen
    Division of Epidemiology and Biostatistics, University of Arizona College of Public Health, Tucson, Arizona 85724 5211, USA
    Cancer 113:907-15. 2008
    ..The objective of the current study was to investigate whether hip BMD predicts postmenopausal breast cancer risk independently of the Gail score...
  13. ncbi request reprint Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease
    Ross L Prentice
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Epidemiol 163:589-99. 2006
    ..An application to postmenopausal hormone treatment effects on coronary heart disease among younger women is also provided...
  14. ncbi request reprint Calcium plus vitamin D supplementation and the risk of fractures
    Rebecca D Jackson
    Division of Endocrinology, Ohio State University, 485 McCampbell, 1581 Dodd Dr, Columbus, OH 43210, USA
    N Engl J Med 354:669-83. 2006
    ..The efficacy of calcium with vitamin D supplementation for preventing hip and other fractures in healthy postmenopausal women remains equivocal...
  15. ncbi request reprint Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial
    Barbara V Howard
    MedStar Research Institute Howard University, Washington, DC, USA
    JAMA 295:655-66. 2006
    ..Multiple epidemiologic studies and some trials have linked diet with cardiovascular disease (CVD) prevention, but long-term intervention data are needed...
  16. ncbi request reprint Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial
    Shirley A A Beresford
    Department of Epidemiology, University of Washington, Seattle, WA 98195 7236, USA
    JAMA 295:643-54. 2006
    ..Observational studies and polyp recurrence trials are not conclusive regarding the effects of a low-fat dietary pattern on risk of colorectal cancer, necessitating a primary prevention trial...
  17. ncbi request reprint Risk-benefit profiles of raloxifene for women
    Marcia L Stefanick
    N Engl J Med 355:190-2. 2006
  18. ncbi request reprint Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
    Jacques E Rossouw
    Women s Health Initiative Branch, National Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA
    JAMA 297:1465-77. 2007
    ..The timing of initiation of hormone therapy may influence its effect on cardiovascular disease...
  19. ncbi request reprint Estrogen therapy and coronary-artery calcification
    JoAnn E Manson
    Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
    N Engl J Med 356:2591-602. 2007
    ..We examined the relationship between estrogen therapy and coronary-artery calcium in the context of a randomized clinical trial...
  20. ncbi request reprint Factors associated with 5-year risk of hip fracture in postmenopausal women
    John Robbins
    Department of Internal Medicine, University of California at Davis School of Medicine, Sacramento, CA 95817, USA
    JAMA 298:2389-98. 2007
    ..The 329,000 hip fractures that annually occur in the United States are associated with high morbidity, mortality, and cost. Identification of those at high risk is a step toward prevention...
  21. doi request reprint Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women
    Anne McTiernan
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Breast Cancer Res Treat 108:217-31. 2008
    ..These results suggest that while age, oophorectomy status, and NSAID use may be associated with selected sex hormone concentrations, few menstrual or reproductive factors affect endogenous sex hormones in the postmenopausal period...
  22. doi request reprint A prospective study of the effect of hypertension and baseline blood pressure on cognitive decline and dementia in postmenopausal women: the Women's Health Initiative Memory Study
    Karen C Johnson
    Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennesse 38163, USA
    J Am Geriatr Soc 56:1449-58. 2008
    ..To examine the relationship between baseline hypertension, blood pressure, and the development of cognitive decline in participants in the Women's Health Initiative Memory Study (WHIMS)...
  23. pmc Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux
    Zongli Zheng
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Gastroenterology 135:72-81. 2008
    ..An association between female hormones and symptomatic gastroesophageal reflux disease (GERD) and may be modified by obesity is suggested but not proven. Factors affecting GERD progression, however, are largely unknown...
  24. doi request reprint Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin
    Gerardo Heiss
    University of North Carolina, School of Public Health, Department of Epidemiology, Chapel Hill, NC 27514 3628, USA
    JAMA 299:1036-45. 2008
    ..The Women's Health Initiative (WHI) trial of estrogen plus progestin vs placebo was stopped early, after a mean 5.6 years of follow-up, because the overall health risks of hormone therapy exceeded its benefits...
  25. pmc Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer
    Cheryl L Rock
    Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California San Diego, 3855 Health Sciences Drive, La Jolla, CA 92093 0901, USA
    Cancer Epidemiol Biomarkers Prev 17:614-20. 2008
    ....
  26. pmc Estrogen plus progestin therapy and breast cancer in recently postmenopausal women
    Ross L Prentice
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Epidemiol 167:1207-16. 2008
    ..64 (95% confidence interval: 1.00, 2.68) over a 5-year period of use and 2.19 (95% confidence interval: 1.56, 3.08) over a 10-year period of use...
  27. doi request reprint Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy
    Rowan T Chlebowski
    Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA 90502, USA
    Arch Intern Med 168:370-7; quiz 345. 2008
    ..The effect of combined hormone therapy on breast cancer detection is not established...
  28. ncbi request reprint Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial
    Ross L Prentice
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Wash 98109, USA
    JAMA 295:629-42. 2006
    ..The hypothesis that a low-fat dietary pattern can reduce breast cancer risk has existed for decades but has never been tested in a controlled intervention trial...
  29. ncbi request reprint Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial
    Jane A Cauley
    Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA 15261, USA
    JAMA 290:1729-38. 2003
    ..In the Women's Health Initiative trial of estrogen-plus-progestin therapy, women assigned to active treatment had fewer fractures...
  30. ncbi request reprint Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study
    Sally A Shumaker
    Department of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    JAMA 291:2947-58. 2004
    ..The Women's Health Initiative Memory Study (WHIMS) previously found increased risk for dementia and no effect on mild cognitive impairment (MCI) in women treated with conjugated equine estrogens (CEE) plus medroxyprogesterone acetate (MPA)...
  31. ncbi request reprint Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial
    Stephen R Rapp
    Department of Psychiatry and Behavioral Medicine, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    JAMA 289:2663-72. 2003
    ..On July 8, 2002, the estrogen plus progestin therapy in the WHI trial was discontinued because of certain increased health risks for women...
  32. ncbi request reprint Menopausal symptoms in older women and the effects of treatment with hormone therapy
    Vanessa M Barnabei
    Medical College of Wisconsin, Milwaukee 53226, USA
    Obstet Gynecol 100:1209-18. 2002
    ..The frequency and severity of such symptoms and response to hormone therapy in older women have not been well documented...
  33. ncbi request reprint Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial
    Garnet L Anderson
    Fred Hutchinson Cancer Research Center, Seattle, Wash 98109 1024, USA
    JAMA 291:1701-12. 2004
    ..Despite decades of use and considerable research, the role of estrogen alone in preventing chronic diseases in postmenopausal women remains uncertain...
  34. ncbi request reprint Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial
    Rowan T Chlebowski
    Harbor UCLA Research and Education Institute, Torrance 90502, USA
    JAMA 289:3243-53. 2003
    ..Outstanding issues not previously addressed include characteristics of breast cancers observed among women using hormones and whether diagnosis may be influenced by hormone effects on mammography...
  35. ncbi request reprint The rise and fall of menopausal hormone therapy
    Elizabeth Barrett-Connor
    Division of Epidemiology, Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, 92093 0607, USA
    Annu Rev Public Health 26:115-40. 2005
    ..Differences between EPT and ET may reflect chance, baseline differences between the EPT and ET cohorts, or a progestin effect. Studies of younger women and lower HT doses with intermediate endpoints are beginning...
  36. ncbi request reprint Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States)
    Libby M Morimoto
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Cancer Causes Control 13:741-51. 2002
    ....
  37. ncbi request reprint Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study
    Barbara V Howard
    MedStar Research Institute, Washington, DC, USA
    Circulation 111:1462-70. 2005
    ..This study compared CVD risk factors and rates between postmenopausal women who had and had not undergone hysterectomy, with or without oophorectomy...
  38. ncbi request reprint Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial
    Ross L Prentice
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Epidemiol 162:404-14. 2005
    ..These analyses have implications for both the design and the analysis of observational studies...
  39. ncbi request reprint Walking compared with vigorous exercise for the prevention of cardiovascular events in women
    JoAnn E Manson
    Division of Preventive Medicine, Harvard Medical School and Brigham and Women s Hospital, Boston 02215, USA
    N Engl J Med 347:716-25. 2002
    ..The role of walking, as compared with vigorous exercise, in the prevention of cardiovascular disease remains controversial. Data for women who are members of minority racial or ethnic groups are particularly sparse...
  40. ncbi request reprint Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial
    Jacques E Rossouw
    Division of Women s Health Initiative, National Heart, Lung, and Blood Institute, 6705 Rockledge Dr, One Rockledge Ctr, Suite 300, Bethesda, MD 20817
    JAMA 288:321-33. 2002
    ..Despite decades of accumulated observational evidence, the balance of risks and benefits for hormone use in healthy postmenopausal women remains uncertain...
  41. ncbi request reprint Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer
    Francesmary Modugno
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 516A Parran Hall, 130 DeSoto Street, Pittsburgh, PA 15261, USA
    Int J Cancer 118:1292-301. 2006
    ..Estrogen metabolism differs according to both BMI and HT use, potentially explaining the interaction between BMI and HT in relation to breast cancer risk...
  42. doi request reprint Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative
    Marian L Neuhouser
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Epidemiol 167:1247-59. 2008
    ..The authors confirm the existence of systematic bias in dietary self-reports and provide methods of correcting for measurement error...
  43. pmc Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women's Health Initiative coronary artery calcium study
    Matthew A Allison
    University of California San Diego, La Jolla, CA, USA
    Menopause 15:639-47. 2008
    ..In this study, we aimed to determine the associations between coronary artery calcium (CAC) and hysterectomy, oophorectomy, and hormone therapy use with a focus on the duration of menopause for which there was no hormone therapy use...
  44. pmc Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events
    Paul F Bray
    Cardeza Foundation for Hematologic Research and Jefferson Medical College, Philadelphia, Pennsylvania, USA
    Am J Cardiol 101:1599-1605. 2008
    ..However, women with favorable lipid levels, especially LDL/HDL cholesterol ratio <2.5, did not have increased risk of coronary heart disease with CEE with or without MPA irrespective of hs-CRP...
  45. ncbi request reprint A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study
    John P Pierce
    Cancer Center, University of California, San Diego, CA 92093 0645, USA
    Control Clin Trials 23:728-56. 2002
    ..We will assess evidence of effectiveness by the length of the breast cancer event-free interval, as well as by overall survival separately in all the women in the study as well as specifically in women under and over the age of 55 years...
  46. pmc Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women
    Andrea Z LaCroix
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    J Am Geriatr Soc 56:1434-41. 2008
    ..To evaluate the association between chronic kidney disease and incident hip fracture using serum cystatin-C as a biomarker of renal function calculated without reference to muscle mass...
  47. doi request reprint Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial
    Lesley F Tinker
    Women s Health Initiative, Fred Hutchinson Cancer Research Center, PO Box 19024, Mail Stop M3 A410, Seattle, WA 98109, USA
    Arch Intern Med 168:1500-11. 2008
    ..This study was undertaken to assess the effects of a low-fat dietary pattern on incidence of treated diabetes among generally healthy postmenopausal women...
  48. doi request reprint Calcium, vitamin D supplementation, and physical function in the Women's Health Initiative
    Robert L Brunner
    University of Nevada School of Medicine, PMB 251, MS 145, Reno, NV 89557, USA
    J Am Diet Assoc 108:1472-9. 2008
    ..Now we examine whether the treatment affected self-reported physical functioning and objective measures of physical functioning...
  49. ncbi request reprint Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial
    Barbara V Howard
    MedStar Research Institute, Washington, DC, USA
    JAMA 295:39-49. 2006
    ....
  50. ncbi request reprint Plasma triacylglycerol and HDL cholesterol concentrations confirm self-reported changes in carbohydrate and fat intakes in women in a diet intervention trial
    Cheryl L Rock
    Department of Family and Preventive Medicine, Reproductive Medicine, and Medicine, University of California, San Diego, CA, USA
    J Nutr 134:342-7. 2004
    ..The degree of change in these lipid concentrations was small and does not suggest increased cardiovascular disease risk...
  51. ncbi request reprint Postmenopausal hormone therapy and body composition--a substudy of the estrogen plus progestin trial of the Women's Health Initiative
    Zhao Chen
    Division of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ 85724, USA
    Am J Clin Nutr 82:651-6. 2005
    ..It has been suggested that hormone therapy may help counter undesirable changes in body composition in older women...
  52. ncbi request reprint Calcium plus vitamin D supplementation and the risk of colorectal cancer
    Jean Wactawski-Wende
    Department of Social and Preventive Medicine, University at Buffalo, 270 Farber Hall, Buffalo, NY 14214, USA
    N Engl J Med 354:684-96. 2006
    ..However, randomized-trial evidence that calcium with vitamin D supplementation is beneficial in the primary prevention of colorectal cancer is lacking...
  53. ncbi request reprint Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer
    Bette J Caan
    Division of Research, Kaiser Permanente Medical Group, 2000 Broadway, 94612 Oakland, CA, USA
    Breast Cancer Res Treat 99:47-57. 2006
    ..To examine whether weight gain after diagnosis of breast cancer affects the risk of breast cancer recurrence...
  54. ncbi request reprint Dietary factors and vasomotor symptoms in breast cancer survivors: the WHEL Study
    Ellen B Gold
    Division of Epidemiology, Department of Public Health Sciences, University of California, Davis, Davis, CA 95616, USA
    Menopause 13:423-33. 2006
    ....
  55. ncbi request reprint Association between reported alcohol intake and cognition: results from the Women's Health Initiative Memory Study
    Mark A Espeland
    Department of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    Am J Epidemiol 161:228-38. 2005
    ..Moderate levels of alcohol intake may be associated with better cognition and reduced risk of significant cognitive decline; however, confounding associations with unmeasured factors cannot be ruled out...
  56. ncbi request reprint Insulin, physical activity, and caloric intake in postmenopausal women: breast cancer implications
    Rowan T Chlebowski
    Los Angeles Biomedical Research Institute at Harbor UCLA, Torrance, CA 90502, USA
    J Clin Oncol 22:4507-13. 2004
    ..However, there are few data on the relative contribution of physical activity, caloric intake, and BMI to fasting insulin levels...
  57. pmc Tamoxifen, hot flashes and recurrence in breast cancer
    Joanne E Mortimer
    Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA 92093 0901, USA
    Breast Cancer Res Treat 108:421-6. 2008
    ..The strength of this finding suggests that further study of the relationship between hot flashes and breast cancer progression is warranted. Additional work is warranted to clarify the mechanism of hot flashes in this setting...
  58. pmc Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity
    John P Pierce
    Cancer Prevention and Control Program, Moores University of California, San Diego Cancer Center, La Jolla, CA 92093 0901, USA
    J Clin Oncol 25:2345-51. 2007
    ..Single-variable analyses have associated physical activity, diet, and obesity with survival after breast cancer. This report investigates interactions among these variables...
  59. pmc Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial
    John P Pierce
    Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA 92093 0901, USA
    JAMA 298:289-98. 2007
    ..Evidence is lacking that a dietary pattern high in vegetables, fruit, and fiber and low in total fat can influence breast cancer recurrence or survival...
  60. ncbi request reprint Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer
    Cheryl L Rock
    Department of Family and Preventive Medicine, University of California San Diego, CA 92093 0901, USA
    J Clin Oncol 22:2379-87. 2004
    ..Diet intervention trials are testing whether postdiagnosis dietary modification can influence breast cancer recurrence and survival. One possible mechanism is an effect on reproductive steroid hormones. Participants and..
  61. pmc Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative
    Ian H De Boer
    Division of Nephrology, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195, USA
    Diabetes Care 31:701-7. 2008
    ..We examined the effect of calcium plus vitamin D supplementation on the incidence of drug-treated diabetes in postmenopausal women...
  62. ncbi request reprint Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002 : Section 4: lessons from hormone replacement trials
    David D Waters
    Circulation 109:e53-5. 2004
  63. ncbi request reprint Telephone counseling intervention increases intakes of micronutrient- and phytochemical-rich vegetables, fruit and fiber in breast cancer survivors
    John P Pierce
    Cancer Prevention and Control Program, Cancer Center, University of California, San Diego, La Jolla, CA, USA
    J Nutr 134:452-8. 2004
    ....
  64. pmc Reliability of plasma carotenoid biomarkers and its relation to study power
    Wael K Al-Delaimy
    Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA 92093 0901, USA
    Epidemiology 19:338-44. 2008
    ..We assessed reliability of plasma carotenoid levels over time and how it could influence study power through sample size and effect-size...

Research Grants7

  1. Outcomes of Sleep Disorders in Older Men-Palo Alto
    Marcia Stefanick; Fiscal Year: 2007
    ..We will also supplement the bank of MrOS specimens to allow for testing of future hypotheses concerning the role of sleep in the development of age-related diseases and conditions. ..
  2. OSTEOPOROTIC FRACTURES IN MEN
    Marcia Stefanick; Fiscal Year: 2007
    ....